These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8299652)
1. Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma. Tenenbaum F; Schlumberger M; Bonnin F; Lumbroso J; Aubert B; Benali H; Parmentier C Eur J Nucl Med; 1993 Dec; 20(12):1168-74. PubMed ID: 8299652 [TBL] [Abstract][Full Text] [Related]
2. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma. Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573 [TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515 [TBL] [Abstract][Full Text] [Related]
4. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases. Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579 [TBL] [Abstract][Full Text] [Related]
5. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Lind P; Gallowitsch HJ Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519 [TBL] [Abstract][Full Text] [Related]
6. Nuclear medicine approaches in the monitoring of thyroid cancer patients. Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A J BUON; 2006; 11(4):511-8. PubMed ID: 17309186 [TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591 [TBL] [Abstract][Full Text] [Related]
8. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer. Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387 [TBL] [Abstract][Full Text] [Related]
9. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma. Kosuda S; Yokoyama H; Katayama M; Yokokawa T; Kusano S; Yamamoto O Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909 [TBL] [Abstract][Full Text] [Related]
10. Potential of (99m)Tc-MIBI for detecting bone marrow metastases. Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520 [TBL] [Abstract][Full Text] [Related]
11. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995 [TBL] [Abstract][Full Text] [Related]
12. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation. Dadparvar S; Chevres A; Tulchinsky M; Krishna-Badrinath L; Khan AS; Slizofski WJ Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487 [TBL] [Abstract][Full Text] [Related]